Physician profile
Todd K Pridmore
NPI 1376097113
$3,274.76
in general payments reported to CMS, 2019-2025
13 companies · $1,519 in 2025
The $1,519 reported for 2025 was more than what 90% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23.38 · 2022: $190 · 2023: $689 · 2024: $854 · 2025: $1,519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,252 · Travel and Lodging: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,251.62 |
| Travel and Lodging | $809.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,368.71 | 2024-2025 | Inspire |
| Harmony Biosciences LLC | $897.22 | 2021-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $371.56 | 2022-2025 | |
| Axsome Therapeutics, INC. | $231.99 | 2023-2024 | Sunosi |
| Avadel Cns Pharmaceuticals, LLC | $185.94 | 2023-2025 | Lumryz |
| 3b Medical, INC. | $42.60 | 2024 | Luna |
| Viatris Specialty LLC | $41.76 | 2025 | Yupelri |
| Philips North America LLC | $29.38 | 2024 | (Ak6) Vest Therapy |
| Mylan Specialty L.P. | $26.31 | 2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $22.12 | 2024 | Dupixent |
| Lilly USA, LLC | $21.67 | 2025 | Zepbound |
| United Therapeutics Corporation | $20.20 | 2024 | Tyvaso |
| Resmed Corp | $15.30 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Pridmore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.